rs866504928

Variant summary

Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PVS1_StrongPM2PP5

The NM_012232.6(CAVIN1):​c.471+1G>T variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000706 in 1,416,954 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (no stars).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.1e-7 ( 0 hom. )

Consequence

CAVIN1
NM_012232.6 splice_donor, intron

Scores

4
2
1
Splicing: ADA: 1.000
2

Clinical Significance

Pathogenic no assertion criteria provided P:1

Conservation

PhyloP100: 7.79

Publications

0 publications found
Variant links:
Genes affected
CAVIN1 (HGNC:9688): (caveolae associated protein 1) This gene encodes a protein that enables the dissociation of paused ternary polymerase I transcription complexes from the 3' end of pre-rRNA transcripts. This protein regulates rRNA transcription by promoting the dissociation of transcription complexes and the reinitiation of polymerase I on nascent rRNA transcripts. This protein also localizes to caveolae at the plasma membrane and is thought to play a critical role in the formation of caveolae and the stabilization of caveolins. This protein translocates from caveolae to the cytoplasm after insulin stimulation. Caveolae contain truncated forms of this protein and may be the site of phosphorylation-dependent proteolysis. This protein is also thought to modify lipid metabolism and insulin-regulated gene expression. Mutations in this gene result in a disorder characterized by generalized lipodystrophy and muscular dystrophy. [provided by RefSeq, Nov 2009]
CAVIN1 Gene-Disease associations (from GenCC):
  • congenital generalized lipodystrophy type 4
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Berardinelli-Seip congenital lipodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 7 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.5370844 fraction of the gene.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-42422626-C-A is Pathogenic according to our data. Variant chr17-42422626-C-A is described in ClinVar as [Pathogenic]. Clinvar id is 30330.Status of the report is no_assertion_criteria_provided, 0 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CAVIN1NM_012232.6 linkc.471+1G>T splice_donor_variant, intron_variant Intron 1 of 1 ENST00000357037.6 NP_036364.2 Q6NZI2-1
CAVIN1XM_005257242.5 linkc.471+1G>T splice_donor_variant, intron_variant Intron 1 of 1 XP_005257299.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CAVIN1ENST00000357037.6 linkc.471+1G>T splice_donor_variant, intron_variant Intron 1 of 1 1 NM_012232.6 ENSP00000349541.4 Q6NZI2-1
ENSG00000294400ENST00000723360.1 linkn.59C>A non_coding_transcript_exon_variant Exon 1 of 4

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
7.06e-7
AC:
1
AN:
1416954
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
701294
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32236
American (AMR)
AF:
0.0000263
AC:
1
AN:
38092
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25390
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36824
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81020
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49718
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5638
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1089344
Other (OTH)
AF:
0.00
AC:
0
AN:
58692
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Congenital generalized lipodystrophy type 4 Pathogenic:1
Sep 01, 2010
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.42
D
BayesDel_noAF
Pathogenic
0.37
CADD
Pathogenic
36
DANN
Uncertain
0.99
Eigen
Pathogenic
1.1
Eigen_PC
Pathogenic
0.93
FATHMM_MKL
Uncertain
0.94
D
PhyloP100
7.8
GERP RS
4.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.94
SpliceAI score (max)
1.0
Details are displayed if max score is > 0.2
DS_DL_spliceai
1.0
Position offset: 1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs866504928; hg19: chr17-40574644; API